The present invention relates to advanced topical formulations of pharmaceutically acceptable salts of Heparin providing enhanced transdermal penetration. The present invention provides clear, non-sticky liquid formulations in which the drug is ready-for-absorption and which are suitable for administration in the fo...
Disclosed herein are injectable compositions containing high concentration of paracetamol or its pharmaceutically acceptable salts wherein the concentration of paracetamol or its pharmaceutically acceptable salt is >150mg/ml in a judiciously tailored solvent system comprising glycofurol, ethanol, water or a solvent ...
Vitamin B-12 deficiency is very common among population. The main causes of B-12 deficiency include lack of intrinsic factors and other intestinal factors (e.g. malabsorption), rare genetic disorders, and inadequate intake. The present invention relates to intranasal formulations of vitamin B derivatives such as met...
The condition wherein the stomach contains an excessive amount of hydrochloric acid is called as hyperacidity and is often associated with other conditions such as flatulence. The present invention provides formulations of antacids in combination with anti-flatulents suitable for the treatment of such conditions of ...
The present invention provides a pharmaceutical composition comprising angiotensin II receptor antagonist telmisartan and process for preparing the same, wherein said composition devoid of use of any surfactants.
Disclosed herein a fluid dispensing massage device capable of being dispense desired fluid and massaging the concerned area using said device without dispensing additional fluid. The device comprising an upstanding body with hollow interior defining a central vertical axis, a neck portion having an open mouth, a hol...
Disclosed herein is a non-gastro retentive composition comprising a therapeutically effective amount of methylcobalamin or its pharmaceutically acceptable forms and process for preparing the same, wherein said composition provide sustained blood levels of methylcobalamin for several hours i.e. for 24 hours without h...
Disclosed herein are injectable compositions containing high concentration of paracetamol or its pharmaceutically acceptable salts wherein the concentration of paracetamol or its pharmaceutically acceptable salt is >150mg/ml in a judiciously tailored solvent system comprising glycofurol, ethanol, water or a solvent ...
Oromucosal Solutions of Zolpidem or Pharmaceutically acceptable Salts thereof
The present invention relates to buccal or sublingual formulations of Zolpidem or pharmaceutically acceptable salt thereof. The formulations minimize the amount of penetration enhancers and yet provide rapid transmucosal penetration of th...
Oromucosal Solutions of Zolpidem or Pharmaceutically acceptable Salts thereof
The present invention relates to buccal or sublingual formulations of Zolpidem or pharmaceutically acceptable salt thereof. The formulations minimize the amount of penetration enhancers and yet provide rapid transmucosal penetration of th...